Inhibition of Cyclooxygenase-2 Reduces Hypothalamic Excitation in Rats with Adriamycin-Induced Heart Failure

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Zheng, Min ^a,b   Kang, Yu Ming ^c   Liu, Wei ^a   Zang, Wei Jin ^c   Bao, Cui Yu ^b   Qin, Da Nian ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CELECOXIB; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2; DOXORUBICIN; GLUTAMIC ACID; NORADRENALIN; SODIUM CHLORIDE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EXCITATION; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PEAK SYSTOLIC PRESSURE; HEART MUSCLE ATROPHY; HEART PROTECTION; HEART RATE; HEART VENTRICLE PRESSURE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; LUNG CONGESTION; LUNG TO BODY WEIGHT RATIO; MALE; MORTALITY; MYOCARDIAL DISEASE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VENTRICLE TO BODY WEIGHT RATIO;

ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOXORUBICIN; HEART FAILURE; HYPOTHALAMUS; MYOCARDIUM; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS;

RATTUS;

EID: 84869013744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048771     Document Type: Article

References (45)

1. Francis J, Zhang ZH, Weiss RM, Felder RB, (2004) Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol 287: H791-H797.
2. Zanzinger J, Czachurski J, (2000) Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch 439: 489-494.
3. Kang YM, He RL, Yang LM, Qin DN, Guggilam A, et al. (2009) Brain tumour necrosis factor-a modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovas Res 83: 737-746.
4. Swanson LW, Sawchenko PE, (1980) Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31: 410-417.
5. Boudaba C, Szabo K, Tasker JG, (1996) Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J Neurosci 16: 7151-7160.
6. Antonaccio MJ, Kerwin L, Taylor DG, (1978) Reductions in blood pressure, heart rate and renal sympathetic nerve discharge in cats after the central administration of muscimol, a GABA agonist. Neuropharmacology 17: 783-791.
7. Brennan TJ, Haywood JR, Ticku MK, (1983) GABA receptor binding and hemodynamic responses to ICV GABA in adult spontaneously hypertensive rats. Life Sci 33: 701-709.
8. Arabia AM, Catapano L, Storini C, Perego C, De Luigi A, et al. (2002) Impaired central stress-induced release of noradrenaline in rats with heart failure: a microdialysis study. Neuroscience 114: 591-599.
9. Zhang K, Li YF, Patel KP, (2002) Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 282: R1006-R1015.
10. Francis J, Wei SG, Weiss RM, Felder RB, (2004) Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol 287: H2138-H2146.
11. Zhang ZH, Wei SG, Francis J, Felder RB, (2003) Cardiovascular and renal sympathetic activation by blood-borne TNF in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 284: R916-R927.
12. Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, et al. (2008) Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappa B. Cardiovasc Res. 79: 671-678.
13. KangYM, Zhang ZH, Xue B, Weiss RM, Felder RB, (2008) Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 295: H227-H236.
14. Kang YM, Zhang ZH, Johnson RF, Yu Y, Beltz T, et al. (2006) Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res 99: 758-766.
15. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M, (2005) Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 338: 70-76.
16. Ericsson A, Arias C, Sawchenko PE, (1997) Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 17: 7166-7179.
17. Hoffman WE, Schmid PG, (1979) Cardiovascular and antidiuretic effects of central prostaglandin E2. J Physiol 288: 159-169.
18. Yu Y, Kang YM, Zhang ZH, Wei SG, Chu Y, et al. (2007) Increased cyclooxygenase-2 expression in hypothalamic paraventricular nucleus in rats with heart failure: role of nuclear factor kappa B. Hypertension. 49: 511-518.
19. Delgado RM 3rd, Nawar MA, Zewail AM, Kar B, Vaughn WK, et al (2004) Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure. Circulation 109: 1428-1433.
20. Braunwald E, Bristow MR (2000) Congestive heart failure: fifty years of progress. Circulation 102: IV14-IV 23.
21. Pieske B, Hasenfuss G, (2000) Pathophysiological basis of heart failure. Ther Umsch 57: 284-292.
22. Dieterich HA, Wendt C, Saborowski F, (2005) Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Fiziol Cheloveka 31: 97-105.
23. Liang CS, (2007) Cardiac sympathetic nerve terminal function in congestive heart failure. Acta Pharmacol Sin 28: 921-927.
24. Helwig BG, Musch TI, Craig RA, Kenney MJ, (2007) Increased interleukin-6 receptor expression in the paraventricular nucleus of rats with heart failure. Am J Physiol Regul Integr Comp Physiol 292: R1165-R1173.
25. Li T, Singal PK, (2000) Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by Probucol. Circulation 102(17): 2105-2110.
26. Rabelo E, De Angelis K, Bock P, Gatelli Fernandes T, Cervo F, et al. (2001) Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure. Hypertension 38: 576-580.
27. Siveski-Iliskovic N, Kaul N, Singal PK, (1994) Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89: 2829-2835.
28. Van Acker SA, Kramer K, Voest EE, Grimbergen JA, Zhang J, et al. (1996) Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice: a new model to test potential protectors. Cancer Chemother Pharmacol 38: 95-101.
29. Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, et al. (2003) Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107: 896-904.
30. Lindley TE, Doobay MF, Sharma RV, Davisson RL, (2004) Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 94: 402-409.
31. Tan J, Wang H, Leenen FH, (2004) Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286: H1665-H1671.
32. Zucker IH, (2006) Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48: 1005-1011.
33. Johnson AK, Thunhorst RL, (1997) The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 18: 292-353.
34. McKinley MJ, McAllen RM, Pennington GL, Smardencas A, Weisinger RS, et al. (1996) Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain. Clin Exp Pharmacol Physiol Suppl 3: S99-S104.
35. Oldfield BJ, Davern PJ, Giles ME, Allen AM, Badoer E, et al. (2001) Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol 13: 139-146.
36. Raasch W, Wittmershaus C, Dendorfer A, Voges I, Pahlke F, et al. (2006) Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology 147: 3539-3546.
37. Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, et al. (2005) Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept 128: 227-238.
38. Catt KJ, Millan MA, Wynn PC, Mendelsohn FA, Aguilera G, (1987) Brain receptors for hypothalamic hormones. Adv Biochem Psychopharmacol 43: 51-67.
39. McKinley MJ, Allen AM, Mathai ML, May C, McAllen RM, et al. (2001) Brain angiotensin and body fluid homeostasis. Jpn J Physiol 51: 281-289.
40. American Physiological Society (2002) Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283.
41. MohanKumar SM, MohanKumar PS, Quadri SK, (1998) Specificity of interleukin-1 induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist. Brain Res Bull 47: 29-34.
42. Huang J, Weiss ML, (1999) Characterization of the central cell groups regulating the kidney in the rat. Brain Res 845: 77-91.
43. Aston-Jones G, Zhu Y, Card JP, (2004) Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J Neurosci 24: 2313-2321.
44. Jaimes EA, Tian RX, Pearse D, Raij L, (2005) Upregulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int 68: 2143-2153.
45. Ouyang C, Guo L, Lu Q, Xu X, Wang H, (2007) Enhanced activity of GABA receptors inhibits glutamate release induced by focal cerebral ischemia in rat striatum. Neurosci Lett 420: 174-178.